added a research activity or funding: Prospective multi-arm blinded randomized study to evaluate if ZTLIDO 1.8% is an effective treatment and prevention modality for chronic post-operative pain (CPOP) through down regulation of acute post-operative inflammatory response and pain in post-thoracotomy surgery.